GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » ROIC %

SLS BIO Co (XKRX:246250) ROIC % : 18.32% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. SLS BIO Co's annualized return on invested capital (ROIC %) for the quarter that ended in Mar. 2024 was 18.32%.

As of today (2024-05-25), SLS BIO Co's WACC % is 8.59%. SLS BIO Co's ROIC % is 9.61% (calculated using TTM income statement data). SLS BIO Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


SLS BIO Co ROIC % Historical Data

The historical data trend for SLS BIO Co's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co ROIC % Chart

SLS BIO Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROIC %
Get a 7-Day Free Trial Premium Member Only 10.30 -5.01 0.96 34.45 17.60

SLS BIO Co Quarterly Data
Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
ROIC % Get a 7-Day Free Trial 64.40 - 1.60 18.64 18.32

Competitive Comparison of SLS BIO Co's ROIC %

For the Diagnostics & Research subindustry, SLS BIO Co's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SLS BIO Co's ROIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SLS BIO Co's ROIC % distribution charts can be found below:

* The bar in red indicates where SLS BIO Co's ROIC % falls into.



SLS BIO Co ROIC % Calculation

SLS BIO Co's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROIC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=1031.033 * ( 1 - -35.62% )/( (8319.13 + 7567.278)/ 2 )
=1398.2869546/7943.204
=17.60 %

where

Invested Capital(A: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=11752.854 - 885.832 - ( 2547.892 - max(0, 2043.389 - 6058.218+2547.892))
=8319.13

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=17837.584 - 915.48 - ( 9354.826 - max(0, 1735.743 - 11750.535+9354.826))
=7567.278

SLS BIO Co's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Mar. 2024 is calculated as:

ROIC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=2266.376 * ( 1 - -1.58% )/( (7567.278 + 17567.099)/ 2 )
=2302.1847408/12567.1885
=18.32 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=17837.584 - 915.48 - ( 9354.826 - max(0, 1735.743 - 11750.535+9354.826))
=7567.278

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SLS BIO Co  (XKRX:246250) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, SLS BIO Co's WACC % is 8.59%. SLS BIO Co's ROIC % is 9.61% (calculated using TTM income statement data). SLS BIO Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases. SLS BIO Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


SLS BIO Co ROIC % Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


SLS BIO Co (XKRX:246250) Business Description

Traded in Other Exchanges
N/A
Address
Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229
SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines